Fresenius SE Warned by US FDA Over Red Blood Cells - Bloomberg PDF Print
Bloomberg
Fresenius SE, a provider of dialysis and hospital services, marketed a device to separate red blood cells

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.